HF 2022: DELIVER Extends Benefits of Dapagliflozin to the Full Spectrum of Pts with HF

(3:35)

HF 2022: 2022 Heart Failure Highlights with Dr Mikhail Kosiborod

(4:6)

HF 2022: CCM Therapy in Patients With HFpEF | Dr Cecilia Linde

(4:44)

Top Things to Know: 2022 Guidelines for the Management of Heart Failure

(1:40)

HF 2022: Heart Failure Highlights of 2022 with Prof John Cleland

(4:7)

2022 AHA/ACC/HFSA Guideline for HF Management: Highlights \u0026 Implementation | Dr Michelle Kittleson

(4:1econd)

HF 2022: Heart Failure Highlights with Prof Giuseppe Rosano

(2:41)

HFSA 2022: PROVE-HF: Effect of Sacubitril/Valsartan in HFrEF Pts With MR | Dr James L Januzzi

(7:42)

HF 2022: HELIOS-A: Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis | Dr Garcia-Pavia

(4:43)

HF 2022: CLOROTIC: Combined Loop With Thiazide Diuretics in Pts With Decompensated HF | Dr Trullas

(4:20)

LBCT Recent HF Hospitalization in DELIVER | ESC Congress 2022

(2:52)

HF 2022: SCD Risk Protection for Newly Diagnosed HF Patients | Dr José González-Costello

(2:17)

Heart Failure 2022: Ghrelin-HF: Intravenous Ghrelin In Patients with HFpEF | Prof Lars Lund

(5:12)

STRONG-HF Results

(16:58)

HF 2022: 6M Results of a No-Implant Interatrial Shunt in Pts With Chronic HF | Prof Lars Lund

(7:50)

Sacubitril/Valsartan and Frailty in HFpEF in PARAGON-HF | ESC Congress 2022

(2:42)

[2022 HF Seoul] Heart failure management at ICU - How to manage AHF with cardiogenic shock

(18:4)

ESC TV at #ESCCongress 2022 - DAPA-HF and DELIVER

(2:7)